MedTrace Logo

Pharmacokinetics of Antibiotics in Patients Undergoing Renal Replacement Therapies

NCT03636464 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2023-02-08

No results posted yet for this study

Summary

The study is aiming to describe the pharmacokinetic and pharmacodynamic profile of intravenous meropenem, ertapenem, cefepime, colistin, Ceftazidime/Avibactam , Ceftolozane/Tazobactam , and piperacillin/tazobactam in the plasma and determine how much is removed by Renal Replacement Therapies to ensure adequate dosing

Conditions

  • Renal Replacement Therapy

Interventions

OTHER

Blood collection

Pharmacokinetics

Sponsors & Collaborators

  • University of the Sciences in Philadelphia

    collaborator OTHER

  • Cleveland Clinic Abu Dhabi

    lead OTHER

Principal Investigators

  • Wasim El Nekidy, PharmD · Cleveland Clinic Abu Dhabi

  • Islam Ghazi, PharmD · University of the Sciences

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-01
Primary Completion
2025-07-01
Completion
2026-07-01

Countries

  • United Arab Emirates

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03636464 on ClinicalTrials.gov